LAWSUITS FILED AGAINST BLU, NEPT and CS - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
NEW YORK, NY / ACCESSWIRE / May 3, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
BELLUS Health Inc. (NASDAQ:BLU)
CONTACT JAKUBOWITZ ABOUT BLU:
https://claimyourloss.com/securities/bellus-health-inc-loss-submission-form/?id=15409&from=1
Class Period: September 5, 2019 - July 5, 2020
Lead Plaintiff Deadline : May 17, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: while BLU-5937's "high selectivity" contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company's Phase 2 trial.
Neptune Wellness Solutions Inc. (NASDAQ:NEPT)
CONTACT JAKUBOWITZ ABOUT NEPT:
https://claimyourloss.com/securities/neptune-wellness-solutions-inc-loss-submission-form/?id=15409&from=1
Class Period: July 24, 2019 - February 16, 2021
Lead Plaintiff Deadline: May 17, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Credit Suisse Group AG (NYSE:CS)
CONTACT JAKUBOWITZ ABOUT CS:
https://claimyourloss.com/securities/credit-suisse-group-ag-loss-submission-form/?id=15409&from=1
Class Period: October 29, 2020 - March 31, 2021
Lead Plaintiff Deadline: June 15, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: defendants concealed material defects in the Company's risk policies and procedures and compliance oversight functions and efforts to allow high-risk clients to take on excessive leverage, including Greensill Capital ("Greensill") and Archegos Capital Management ("Archegos"), exposing the Company to billions of dollars in losses.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/643959/LAWSUITS-FILED-AGAINST-BLU-NEPT-and-CS--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS
